Harleysville, PA, United States of America

Emily Wen

USPTO Granted Patents = 7 


Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Emily Wen in Pneumococcal Vaccine Development

Introduction

Emily Wen is an accomplished inventor based in Harleysville, PA (US), known for her significant contributions to the field of immunology. She holds a total of seven patents, showcasing her innovative approaches to vaccine development. Her work primarily focuses on methods for producing capsular polysaccharide carrier protein conjugates, which are crucial for creating effective vaccines against pneumococcal diseases.

Latest Patents

Emily Wen's latest patents include groundbreaking methods for producing pneumococcal capsular polysaccharide protein conjugates. One method describes the process of separately lyophilizing activated pneumococcal polysaccharides of specific serotypes and carrier proteins. These components are then reconstituted in an organic solvent and combined through Tee-mixing to create polysaccharide carrier protein conjugates. This technique allows for the development of multivalent pneumococcal immunogenic compositions, which can enhance vaccine efficacy. Another patent outlines a method for producing these conjugates from lyospheres, where carrier protein and polysaccharide lyospheres are mixed and reconstituted to form the desired conjugates. This innovative approach also aims to produce multivalent immunogenic compositions for vaccines.

Career Highlights

Emily Wen is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research in vaccine development. Her work has been instrumental in improving the effectiveness of pneumococcal vaccines, contributing to public health initiatives aimed at reducing the incidence of pneumococcal diseases.

Collaborations

Emily collaborates with notable colleagues, including Michael Albert Winters and Patrick McHugh, who share her commitment to advancing vaccine technology. Their combined expertise fosters an environment of innovation and progress in the field.

Conclusion

Emily Wen's contributions to the development of pneumococcal vaccines through her innovative methods and collaborative efforts highlight her importance in the field of immunology. Her work not only advances scientific knowledge but also has the potential to significantly impact public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…